Nancy Abd-elkader Hagras
Pharos University in Alexandria, Egypt
Title: Significant efficacy of Spiramycin-Loaded Chitosan Nanoparticles on the treatment of histopathological changes in acute experimental toxoplasmosis
Biography
Biography: Nancy Abd-elkader Hagras
Abstract
Background: The wide distribution of T. gondii infection makes finding a safe and effective drug a great success. Current therapeutics do not clear parasite infection and are hampered by severe adverse effects.
Aim: The present study was carried out to investigate the effect of chitosan nanoparticles (CS NPs), spiramycin, spiramycin co-administered with metronidazole and spiramycin-loaded CS NPs on the parasite load and histopathology in the liver, spleen and brain in Swiss albino mice infected with acute T. gondii (RH strain).
Materials and methods: Seventy male Swiss albino mice were divided into seven equal groups: healthy control (I), infected untreated control (II), infected group receiving CS NPs (III), infected group treated with spiramycin (IV), infected group treated with spiramycin-metronidazole (V), infected treated with spiramycin-loaded CS NPs 400 mg/kg (VI) and infected treated with spiramycin-loaded CS NPs 100 mg/kg (VII). All mice were inoculated intraperitoneally with 2500 T. gondii tachyzoites RH strain except the healthy control group. Mice were sacrificed on the 8thday for liver, spleen and brain parasite load and histopathological studies.
Results: Parasite load and histopathological examination of liver, spleen and brain of all treated mice revealed decrease in the inflammation, congestion, necrosis and mean tachyzoites count within tissue sections. Spiramycin-loaded NPs showed the highest significant reduction in the pathological insult while spiramycin alone revealed the lowest reduction as compared to the other used drugs. Administration of either CS NPs or spiramycin-metronidazole induced a moderate reduction in the pathological changes.
Conclusion: Based on the present research, it can be concluded that spiramycin-loaded CS NPs lead to a pronounced decrease in tachyzoites count and histopathological effects compared to the other used treatments. Thus, spiramycin-loaded CS NPs is a promising synergistic formulation in the treatment of acute toxoplasmosis.